Early Diagnosis
How to identify the early signs of uropathy in young ketamine users.
Clinical Protocols
Management and care practices developed over the past 18 months by the specialized clinic.
Prevention and Safety
Drug safety and the role of public health education.
Specialists
Urologists and pediatricians focused on bladder dysfunction.
Clinicians
Nurses and pelvic floor physiotherapists.
Academics
Public health and toxicology researchers.
Dr. Harriet Corbett
Consultant Paediatric Urologist - Alder Hey Children's Hospital
A graduate of the University of Liverpool, Dr. Corbett is a leading authority in paediatric urology in the UK. She serves. As the CORESS Programme Director and Senior Lecturer, with a clinical focus on bladder function and paediatric urology.
She also co-founded a specialised clinic for the treatment of urinary symptoms related to ketamine use in children and adolescents.
Alongside her surgical practice, she leads research on drug safety and bladder function, supported by the NIHR SCPRA fellowship.
Dr. Stacy Tanaka
Chief of Pediatric Urology at UAB | ICCS Director
Dr. Stacy Tanaka brings her extensive experience as AUANews Editor and ICCS Board Member to guide this high-level discussion.
An internationally recognized expert in bladder dysfunction (neurogenic and non-neurogenic), she will moderate the Q&A session, connecting UK-based evidence with global clinical practice
"An essential discussion on the new frontiers of pediatric continence and modern epidemiological challenges."